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Abstract. 
 
FE65 binds to the Alzheimer amyloid pre-
cursor protein (APP), but the function of this interac-
tion has not been identiﬁed. Here, we report that APP
and FE65 are involved in regulation of cell movement.
APP and FE65 colocalize with actin and Mena, an Abl-
associated signaling protein thought to regulate actin
dynamics, in lamellipodia. APP and FE65 speciﬁcally
concentrate with 
 
 
 
1-integrin in dynamic adhesion sites
known as focal complexes, but not in more static ad-
hesion sites known as focal adhesions. Overexpression
of APP accelerates cell migration in an MDCK cell
wound–healing assay. Coexpression of APP and FE65
dramatically enhances the effect of APP on cell move-
ment, probably by regulating the amount of APP at the
cell surface. These data are consistent with a role for
FE65 and APP, possibly in a Mena-containing macro-
molecular complex, in regulation of actin-based motility.
Key words: amyloid precursor protein • FE65 • Mena
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Introduction
 
Altered proteolytic processing of the Alzheimer amyloid
precursor protein (APP)
 
1
 
 is thought to be at least one
cause of Alzheimer disease. Despite extensive efforts to
pinpoint the normal function of APP, its function in the
cell remains elusive. Roles in cell adhesion (Schubert et
al., 1989), cell proliferation (Saitoh et al., 1989), neuropro-
tection (Mattson et al., 1993) and neurite outgrowth (Mil-
ward et al., 1992; Jin et al., 1994; Small et al., 1994; Perez et
al., 1997) have been proposed. It has also been suggested
that APP might have a role in signal transduction since
APP structurally resembles a receptor (Kang et al., 1987)
and is targeted to the cell surface.
FE65 interacts with the YENPTY motif in the cytoplas-
mic domain of APP (Fiore et al., 1995; Borg et al., 1996;
Bressler et al., 1996; Guenette et al., 1996; Zambrano et
al., 1997; Duilio et al., 1998; Tanahashi and Tabira, 1999).
Aside from its interaction with APP, very little is known
about FE65. It has no known enzymatic activity and con-
tains three protein–protein interaction domains, with a
WW domain in its NH
 
2 
 
terminus and tandem phosphoty-
rosine/protein interaction domains (PIDs) in its COOH
terminus. FE65 binds to APP through its more COOH-
terminal PID. Overexpression of FE65 increases the pro-
teolytic processing of APP (Guenette et al., 1999; Sabo et
al., 1999). It also causes a translocation of APP to the cell
surface (Sabo et al., 1999), suggesting that binding of FE65
to the YENPTY motif might regulate the function of APP
by regulating the amount of APP at the cell surface.
We do not yet know whether, and if so which, other pro-
teins interact with FE65 when FE65 interacts with APP. It
has been shown previously that Mena coprecipitates with the
WW domain of FE65 (Ermekova et al., 1997). Mena is ge-
netically linked to the Abl tyrosine phosphorylation signal-
ing cascade and is required for normal neural development
(Gertler et al., 1990, 1995; Lanier et al., 1999). It localizes to
cell-substrate adhesion sites and sites of dynamic actin as-
sembly and disassembly. Interestingly, Mena also binds to
profilin, placing it in a position to regulate actin dynamics.
It has been proposed that Mena, FE65, and APP may be
components of a tripartite complex (Ermekova et al.,
1997). However, it has not been shown that this tripartite
complex exists.
At the neuronal cell surface, APP colocalizes with patches
of integrins (Yamazaki et al., 1997). Integrins are a family of
heterodimeric cell adhesion receptors that mediate cell–
matrix interactions required for cell proliferation, differenti-
ation, and migration (Howland et al., 1995). This raises the
question of whether an APP–FE65 complex might have
some role in integrin-based adhesion or signaling.
Integrins and Mena are both found in two types of cell-
substrate adhesion sites, known as focal adhesions and fo-
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cal complexes (Hotchin and Hall, 1995; Gertler et al.,
1996; Rottner et al., 1999a; Lanier and Gertler, 2000). Fo-
cal adhesions are the widely studied adhesion sites found
at the tips of actin stress fibers. They are typically very sta-
ble and strong and are found in relatively static regions of
the cell. Focal complexes are less studied, more dynamic
adhesion sites typically found at a migrating cell’s leading
edge (Nobes and Hall, 1995). Although focal adhesions
and focal complexes are functionally and morphologically
distinct, there has been, to our knowledge, no known bio-
chemical distinction between them. It seemed possible
that APP and FE65 might function together in focal adhe-
sions, focal complexes, or both.
Here we show that APP and FE65 selectively localize
with Mena in integrin-based focal complexes in mobile
membrane compartments. Furthermore, we provide evi-
dence that APP modulates cell movement, and that APP-
dependent changes in cell motility are regulated by FE65.
We propose a link between FE65-dependent changes in
APP trafficking and metabolism and actin-based mem-
brane motility.
 
Materials and Methods
 
Tissue Culture
 
Standard tissue culture techniques were used. H4 neuroglioma cells and
MDCK cells were maintained in DME supplemented with 10% FBS and
antibiotics. MDCK cells that overexpress the 695–amino acid isoform of
APP (
 
 
 
APP/
 
 
 
FE65) were a gift of Dr. C. Haass (Ludwig Maximilians
University, Munich, Germany) (Haass et al., 1994). These cells were sta-
bly transfected with FE65 cDNA to yield cells that overexpress both APP
and FE65 (
 
 
 
APP/
 
 
 
FE65; Sabo et al., 1999). FE65 overexpression does
not alter steady-state APP expression levels.
 
Antibodies
 
Polyclonal FE65 antibodies 170/173, which recognize the WW domain of
FE65, were affinity purified as described previously (Sabo et al., 1999).
Polyclonal APP antibody 369, which recognizes the cytoplasmic domain
of APP, was affinity purified with a peptide corresponding to the last 50
amino acids of APP. The APP monoclonal antibodies 5A3/1G7 (a gift
from Dr. E.H. Koo, University of California at San Diego, CA) recognize
epitopes in the extracellular domain of APP. Polyclonal antibodies against
Mena were a gift of Dr. F. Gertler (MIT, Cambridge, MA) and have been
used previously for immunoblotting and immunofluorescence (Ermekova
et al., 1997; Lanier et al., 1999). Integrin 
 
 
 
1 and phosphotyrosine mono-
clonal antibodies were purchased from Upstate Biotechnology.
 
Immunofluorescence
 
H4 cells were plated at 3.5 
 
 
 
 10
 
4
 
 cells/cm
 
 
 
2
 
 in Labtek chamberslides. Cells
were fixed in cold 4% paraformaldehyde in PBS with 0.12 M sucrose for
10 min at room temperature. After permeabilization for 5 min with 0.1%
Triton X-100 in PBS, the cultures were blocked with 10% normal goat se-
rum (NGS) in PBS for 30 min at room temperature. Cells were incubated
overnight at 4
 
 
 
C with primary antibodies diluted in 5% NGS in PBS, then
incubated with secondary antibodies, also diluted in 5% NGS in PBS, for
1 h at room temperature. Coverslips were mounted with DABCO in poly-
vinyl alcohol.
Secondary antibodies were used at dilutions of 1:400 for Oregon green
goat anti–mouse and Texas red goat anti–rabbit (Molecular Probes), 1:200
for Cy5 goat anti–mouse, and 1:100 for rhodamine red X goat anti–rabbit
(Jackson ImmunoResearch Laboratories). Oregon green phalloidin (Mo-
lecular Probes) was used at 1:40 dilution and was added with the second-
ary antibody.
In all cases, immunofluorescence was eliminated by omission of the pri-
mary antibody. For FE65 and APP labeling, the signals were also elimi-
nated by competition with excess soluble antigen (Fig. 3, d and h). In double
and triple label experiments, labeling patterns were identical to those seen
with single labeling. In addition, each labeling pattern was identical when an
alternative set of secondary antibodies was used. Immunofluorescence was
examined by confocal laser scanning microscopy (LSM510; Carl Zeiss, Inc.)
using a 63
 
 
 
 water immersion lens; Ar 488-, HeNe 543-, and HeNe 633-nm
lasers; and BP505-550, BP560-615, and LP650 filters. For colocalization ex-
periments, optical sections were no thicker than 1.5 
 
 
 
m and each channel
was imaged separately, eliminating the possibility of “bleed-through.”
 
Coprecipitation
 
GST fusion proteins were purified from bacterial lysates by incubation
with glutathione-Sepharose beads (Amersham Pharmacia Biotech) fol-
lowed by extensive washing with HBS. Purified fusion proteins were
quantified both by SDS-PAGE followed by Coomassie staining and elu-
tion with glutathione, dialysis, and BCA assay (Pierce Chemical Co.). H4
cells were homogenized in 10 mM Tris HCl, pH 7.5; 150 mM NaCl; 0.1
mM sodium vanadate; 50 mM NaF; 0.5% NP-40 and protease inhibitors.
The beads were blocked with 2% BSA. Extracts were incubated with
equal amounts of various GST fusion proteins for 2–3 h. Complexes pre-
cipitated on glutathione-Sepharose beads were washed several times with
lysis buffer. Beads were then boiled in Laemmli buffer, and the proteins
separated by SDS-PAGE and transferred to nitrocellulose. Blots were
probed with polyclonal primary antibodies and anti–rabbit HRP-conju-
gated IgG (Amersham Pharmacia Biotech), then examined by ECL
(Pierce Chemical Co.).
 
Coimmunoprecipitation
 
Confluent monolayers of MDCK cells were split 1:3 and plated. 24 h later,
cells were homogenized in 0.25% NP-40 in PBS containing a protease in-
hibitor cocktail (Amersham Pharmacia Biotech) and 2% BSA at 4
 
 
 
C. Af-
ter centrifugation for 10 min at 10,000 
 
g
 
, the supernatant was incubated
for 1.5 h at 4
 
 
 
C with Mena antibody precoupled to protein A–Sepharose
beads. The beads were then pelleted and washed several times with lysis
buffer. Immunoprecipitates were boiled in Laemmli buffer and separated
by SDS-PAGE. Immunoblotting was performed in 5% nonfat milk and
0.05% Tween-20 in TBS with 6E10, a monoclonal antibody against APP,
and anti–Flag-M2 antibody to recognize a Flag epitope tag on expressed
FE65. Detection was with anti–mouse HRP-conjugated secondary anti-
body (Amersham Pharmacia Biotech) and ECL (Pierce Chemical Co.).
 
Wounding Assay
 
Wounding assays using MDCK cells have been published previously
(Rosen and Misfeldt, 1980; Fenteany et al., 2000). Confluent monolayers
of MDCK cells were wounded by scraping with a 200-
 
 
 
l pipette tip. Unat-
tached cells were removed by washing and agitation. For immunofluores-
cence, wounded monolayers were allowed to recover for 2 h and were
then fixed and immunostained. For measurements of wound healing, the
cells were grown on grids. Photographs of the wounds were taken at the
same points on the grid at various time points. The distances the wound
edges had traveled were determined by measuring, at each time point, the
distance between the two edges at regular intervals from the grid marker.
In addition, wounds were examined for degree of closure after 
 
 
 
1 d of
wound healing and scored as fully closed, partially closed or fully open.
 
Cross-Correlation Analysis
 
Images were collected for cells labeled as described above. The detector
gain was adjusted such that none of the fluorescence levels reached satu-
ration. A series of 
 
 
 
5–10-
 
 
 
m lines were drawn perpendicular to the
lamellipodial leading edge at intervals of 
 
 
 
3–5 
 
 
 
m. Line length was con-
stant for an individual lamellipodium. An intensity profile was generated
for all three labels along each line. The resulting intensities were com-
pared by cross-correlation analysis. A more detailed description of cross-
correlation analysis can be found elsewhere (Bendat and Piersol, 1971;
Oppenheim and Schafer, 1975; Brody, 1999a,b). To avoid artifacts due to
differences in the overall intensity of each label, the “shuffle-corrected”
cross-correlogram, also referred to as a cross-covariogram, was calculated.
The cross-correlogram and cross-covariogram are essentially equivalent
to correlation and covariance commonly calculated for scalars and given
by the following equations:
rx y 〈〉 =
vx y 〈〉 x 〈〉y 〈〉 – = 
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where 
 
r 
 
is the correlation and 
 
v 
 
is the covariance of two scalars,
 
 x 
 
and 
 
y
 
.
 
 
 
〈 〉
 
indicates the expected value operation. The cross-correlogram and cross-
covariogram are given by the following equations:
where 
 
R(x)
 
 is the cross-correlogram and 
 
V(x)
 
 is the shuffle-corrected corre-
logram. 
 
I(x)
 
 is the intensity along one of the lines. Subscripts denote the la-
bel being examined. The covariograms were calculated using the “xcov”
function in Matlab (signal processing toolbox, Mathworks). The cross-cova-
riograms were normalized such that the shuffle-corrected autocorrelation
equals 1.0 at zero displacement. The autocorrelation is computed by corre-
lating a vector with itself and thus gives the highest correlation possible.
This normalization results in a cross-covariogram in which the values on the
y-axis correspond to the correlation coefficient at each displacement.
 
Results
 
Colocalization of APP and FE65 with Mena 
and Lamellipodial Actin
 
FE65 interacts with Mena in vitro, but the relevance of this
interaction to APP and FE65 function was unknown. Fur-
thermore, it was not known if FE65 interacts with APP and
Mena simultaneously. To test if a tripartite complex be-
tween APP, FE65, and Mena is possible, we triple labeled
H4 human neuroglioma cells either with APP monoclonal
antibody, Mena polyclonal antibody, and Oregon green
phalloidin or with APP monoclonal antibody, FE65 poly-
clonal antibody, and Oregon green phalloidin. The phalloi-
din labeling allowed us to identify the membrane domains
in which APP, FE65, and Mena localized. APP and Mena
colocalized at ruffled edges of cells that contained a charac-
teristic lamellipodial actin structure (Fig. 1, a–d). In fact,
edges that contained APP and Mena could be identified
based solely on the presence of a dense meshwork of short
actin filaments. APP also colocalized with FE65 in lamelli-
podia (Fig. 1, f–i). To avoid over- or underestimation of the
colocalization, we performed a novel, quantitative, objec-
tive analysis of the colocalization (described in Materials
and Methods). Quantification of the intensity of the im-
munofluorescence signals and cross-correlation analysis
showed that APP and Mena (Fig. 1 e) and APP and FE65
(Fig. 1 j) indeed colocalize, since cross-covariograms de-
rived from lamellipodial line intensity profiles displayed
significant correlation with no shift in the peak.
To determine if the APP–FE65–Mena tripartite com-
plex exists, coprecipitations and immunoprecipitations
were performed. When H4 cell lysates were incubated
with a GST fusion protein containing the cytoplasmic do-
main of APP, FE65 was precipitated on glutathione-
Sepharose beads through an interaction with the APP fu-
sion protein (Fig. 2 a). Similarly, when the same lysates
were incubated with a GST fusion protein containing the
WW domain of FE65, Mena bound to the FE65 fusion
protein was precipitated on glutathione-Sepharose beads
(Fig. 2 b). Finally, when lysates from MDCK cells stably
expressing both APP and FE65 were subjected to immu-
noprecipitation with antibodies raised against Mena, FE65
and APP were found in the immunoprecipitates by immu-
noblotting (Fig. 2, c and d). When lysates from MDCK
cells stably expressing only APP were used side-by-side in
the same experiment, APP was not coimmunoprecipitated
Rx () I1 x () I2 x () ⊗ 〈〉 =
Vx () I1 x () I2 x () ⊗ 〈〉 I1 x () 〈〉 I2 x () 〈〉 ⊗ – =
 
with Mena, indicating that the APP found in the immu-
noprecipitates associated with Mena indirectly through
FE65. These data lend strong support to the idea that a
macromolecular complex containing APP, FE65, and
Mena exists in vivo. Since Mena is known to bind to profi-
lin and is thought to regulate actin dynamics (Gertler et
al., 1996; Lanier and Gertler, 2000), the colocalization and
interaction of APP and FE65 with Mena provides evi-
dence for an indirect link between an APP–FE65 complex
and the lamellipodial actin cytoskeleton.
 
Dynamic, but Not Static, Compartments 
Contain APP and FE65
 
To confirm that the membrane domains that contained
APP and FE65 were the dynamic lamellipodial mem-
branes, H4 cells were double labeled with antibodies
against APP and cortactin or FE65 and cortactin. Cortac-
tin is an actin-binding protein highly enriched within
lamellipodia (Wu and Parsons, 1993). Both APP (Fig. 3,
a–c) and FE65 (Fig. 3, e–g) localized specifically to cortac-
tin-rich lamellipodia. The FE65 and APP labeling in lamel-
lipodia was specific, since competition with excess soluble
antigen eliminated lamellipodial staining (Fig. 3, d and h).
The membranes that contained APP and FE65 also con-
tained another marker of dynamic membranes, Rac1 (data
not shown). Rac1 is a member of the Rho family of small
GTP-binding proteins, which, upon activation, is targeted
to membranes where it induces lamellipodia formation
(Bokoch et al., 1994; Nobes and Hall, 1995). This con-
firmed that the labeled edges were indeed the mobile
lamellipodia of the cells.
APP and Mena colocalized in lamellipodia (Fig. 4, b and
f–h) but not in focal adhesions (Fig. 4, b and c–e). Occa-
sionally APP and Mena were seen in fine lines toward the
edges of the lamellipodia, which most likely corresponded
to focal complexes. Focal complexes are integrin-based ad-
hesion sites found at the base of protruding and ruffling
lamellipodia (Hotchin and Hall, 1995; Nobes and Hall,
1995; Rottner et al., 1999b). The lamellipodial actin mesh-
work terminates at the focal complexes, the role of which is
unclear. They are not required for lamellipodial formation,
but might be important for cell movement or signaling.
In the absence of a monoclonal antibody to either FE65
or Mena for double labeling of FE65 and Mena, we tested
whether FE65 was also selectively found in mobile mem-
branes by labeling adhesion sites with antiphosphoty-
rosine antibodies. Tyrosine-phosphorylated proteins accu-
mulate in adhesion sites in both dynamic and static
membranes, making phosphotyrosine a good marker for
both focal adhesions and focal complexes. FE65 colocal-
ized with phosphotyrosine in membrane regions that dis-
played characteristics of lamellipodia, such as actin aggre-
gates and ruffled edges (Fig. 4, i and m–o), but not in focal
adhesions (Fig. 4, i and j–l). Thus, both FE65 and APP se-
lectively localize to mobile membrane compartments con-
taining weak sites of cell–substrate attachment.
 
APP and FE65 in Integrin-based Focal Complexes
 
Several studies have suggested a role for APP in cell adhe-
sion (Mattson, 1997). Given the localization of APP and
FE65 within lamellipodia, it seemed that they might play 
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some role in regulation of adhesion or signaling in integrin-
dependent lamellipodial focal complexes. Since integrins
containing the 
 
 
 
1 integrin subunit are found in focal com-
plexes (Hotchin and Hall, 1995; Rottner et al., 1999b), we
used 
 
 
 
1-integrin as a marker. To determine if FE65 and
APP colocalize with 
 
 
 
1 integrin at adhesion sites in lamel-
lipodia, H4 cells were triple labeled with 
 
 
 
1-integrin mon-
oclonal antibody, Oregon green phalloidin, and either
FE65 or APP polyclonal antibodies. Lamellipodia were
identified and chosen for imaging by their characteristic
ruffled structure and actin meshwork. APP and 
 
 
 
1-integrin
colocalized in lamellipodia (Fig. 5, a–d). A similar pattern
of lamellipodial staining was seen when FE65 antibody was
used (Fig. 5, f–i), as expected from the APP/FE65 colocal-
ization data presented above. Quantitative analysis by
cross-correlation showed that for the labeling of APP and
 
 
 
1-integrin, as well as for APP and actin, the signals were
correlated with no significant shift in the peak, indicating
colocalization (Fig. 5 e). As expected from the colocaliza-
tion of FE65 and APP, the FE65 signal also correlated well
with the 
 
 
 
1-integrin and actin signals (Fig. 5 j). The corre-
lation tended to be better in the middle of the lamellipo-
dia. The focal complexes may not extend to the flanks of
the lamellipodia or there may be preferential colocaliza-
tion in the direction of motion. These data support the idea
that FE65 and APP interact in mobile lamellipodia and
possibly at weak adhesion sites in those membranes.
Often when cells are torn from their substrates, the ad-
hesion sites that had anchored the cell to the substrate are
left behind. These adhesion sites contain many proteins as-
sociated with adhesion sites in intact cells. APP can be
found in such sites (Yamazaki et al., 1997). To test if FE65
is also present in “cell-free” adhesion sites, we looked at
H4 cells labeled with FE65 and 
 
 
 
1-integrin antibodies.
When the lamellipodia were peeled back from the surface
on which the cells were grown, remaining adhesion sites
were labeled with both 
 
 
 
1-integrin antibody and FE65 an-
tibody (Fig. 6, a and b). This is striking since FE65 is ex-
pected to be a soluble protein. To confirm previous reports
about APP, remaining adhesion sites were also labeled
with APP antibody (Fig. 6 c). To confirm the specificity of
the association of FE65 with the APP-containing adhesion
sites, an antibody against X11/Mint2, another cytoplasmic
protein that can interact with the cytoplasmic tail of APP,
was used in parallel. Adhesion sites that contained APP
were not labeled by X11/Mint2 antibody (Fig. 6 d). These
results further support the idea that an FE65–APP com-
plex colocalizes with 
 
 
 
1-integrins at focal complexes.
Finally, when cells were double labeled with monoclonal
APP antibodies and polyclonal Mena antibody, APP and
Figure 1. APP colocalizes with
FE65, Mena, and actin in lamel-
lipodia. Lamellipodia are char-
acterized by aggregates of actin
and a dense meshwork of short
actin filaments and could there-
fore be chosen for imaging based
on their actin structure while
blind to immunolabeling. Images
are presented in pseudocolor.
(a–d) High magnification image
of H4 cells triple labeled with
APP monoclonal antibodies (a),
Mena polyclonal antibody (b),
and Oregon green–conjugated
phalloidin (c), then examined by
confocal microscopy. Overlap of
APP, Mena, and actin is indi-
cated by white in the overlay (d).
(f–i) High magnification image
of H4 cells triple labeled with
APP monoclonal antibodies (f),
FE65 polyclonal antibodies (g),
and Oregon green–conjugated
phalloidin (h), then examined
by confocal microscopy. Over-
lap of APP, FE65, and actin is
indicated by white in the overlay
(i). (e and j) Cross-covariograms
from cross-correlation analysis
of APP, Mena, and actin (e) and
of APP, FE65, and actin (j) in
lamellipodia. Lines were drawn
perpendicular to the lamellipo-
dial edge (shown in orange and
labeled a –e  for APP, Mena, and
actin and f –j  for APP, FE65, and actin). The intensities were determined for each line and the cross-covariograms calculated as described
in Materials and Methods. All of the cross-covariograms calculated here, with the exception of c  for both Mena and actin, have peaks  0.5,
indicating significant correlation. None have a displacement greater than the half-width at half-height, indicating colocalization. Bars, 5  m. 
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Mena could be found associated with the same cell-free
adhesion sites (Fig. 6, e–g), supporting the hypothesis that
FE65 and APP function in focal complexes as part of a
Mena-containing macromolecular complex. The specific
localization of APP and FE65 in focal complexes, but not
focal adhesions, is especially interesting since no differ-
ence in the biochemical composition of these two structur-
ally and functionally different adhesion structures has
been reported previously (Rottner et al., 1999b).
 
FE65 and APP Accumulate at Edges of Lamellipodia 
Induced by Wounding
 
It was recently shown that Mena localizes to focal com-
Figure 2. APP and Mena interact with FE65 simul-
taneously. (a and b) H4 cell lysates were incubated
with GST fusion proteins corresponding to either
the cytoplasmic domain of APP (APP C50-GST) or
the WW domain of FE65 (FE65 WW-GST) for pre-
cipitation with glutathione-Sepaharose. Precipitated
complexes were immunoblotted with FE65 (a) and
Mena (b) antibodies, respectively. As a control for
nonspecific coprecipitation, experiments were
performed in parallel with GST alone. (c and d)
Homogenates from MDCK cells that overex-
pressed both APP and FE65 ( FE65) and
MDCK cells that overexpressed APP, but not
FE65 ( FE65), were immunoprecipitated with
Mena antibodies. The immunoprecipitates were
then immunoblotted with APP (c) and FE65 (d)
antibodies. APP coimmunoprecipitated with
Mena only when FE65 was present.
Figure 3. The membranes enriched in APP and FE65 are also enriched in cortactin, a marker for lamellipodia. (a–c) H4 cells immuno-
labeled with a combination of APP polyclonal antibody (a) and cortactin monoclonal antibody (b). Overlap is indicated by yellow in the
overlay (c). (d) Lamellipodial staining of APP is eliminated by preincubation of APP antibody with excess soluble antigen. (e–g) H4 cells
immunolabeled with a combination of FE65 polyclonal antibodies (e) and cortactin monoclonal antibody (f). Overlap is indicated by yel-
low in the overlay (g). (h) FE65 immunofluorescence is eliminated by preincubation of FE65 antibodies with excess soluble antigen. 
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plexes in protruding lamellipodia (Rottner et al., 1999a).
This suggests that FE65 and APP, possibly in a complex
with Mena, might have a role in membrane extension. To
test further if FE65 and APP could be involved in lamelli-
podial extension, we forced cells into a state in which the
membranes were actively extending and examined APP
and FE65 localization in the induced lamellipodia. To in-
duce motility, confluent monolayers of MDCK cells stably
transfected with both APP and FE65 were wounded with a
pipette tip. In response to wounding, the cells along the
edge of the wound first sent out lamellipodia then eventu-
ally migrated into the wound. We examined APP and
Figure 4. APP and FE65 ac-
cumulate in mobile lamellipo-
dia, but not in focal adhesions.
Arrows indicate the location
of focal complexes and ar-
rowheads indicate the loca-
tion of focal adhesions. (a)
Schematic diagram. Focal
adhesions are found at the
ends of stress fibers in stable
membranes, whereas focal
complexes anchor a mesh-
work of short actin filaments
to the substrate under the
cell’s mobile lamellipodia.
(b–h) H4 cells triple labeled
with a combination of APP
monoclonal antibodies, Mena
polyclonal antibody, and Ore-
gon green phalloidin. Images
of labeled cells were collected
by confocal microscopy. (b)
Overlay of APP (red), Mena
(green), and actin (blue).
Overlap of staining for all
three is indicated by white.
(c–e) Individual signals from
the solid box in panel b for
APP (c), Mena (d), and actin
(e). Notice the absence of
APP immunoreactivity from
focal adhesions. (f–h) Indi-
vidual signals from dashed
box in panel b for APP (f),
Mena (g), and actin (h). No-
tice that APP colocalizes
with Mena in a fine line at
the edge of the lamellipodia.
(i–o) H4 cells triple labeled
with a combination of FE65
polyclonal antibodies, phos-
photyrosine monoclonal anti-
body, and Oregon green
phalloidin. Phosphotyrosine
antibodies were used here as
a marker for adhesion sites
since the FE65 antibody and
the Mena antibody were both
raised in rabbits. (i) Overlay
of FE65 (red), phosphoty-
rosine (green), and actin
(blue). Overlap of staining
for all three is indicated by
white. (j–l) Individual sig-
nals from solid box in panel i
for FE65 (j), phosphoty-
rosine (k), and actin (l). No-
tice the absence of FE65 immunoreactivity from focal adhesions. (m–o) Individual signals from dashed box in panel i for FE65 (m),
phosphotyrosine (n), and actin (o). Notice that lamellipodia are labeled by both FE65 and phosphotyrosine antibodies. Bar, 10  m. 
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FE65 localization in the wounded monolayers by immu-
nofluorescence labeling with monoclonal APP antibodies
and polyclonal FE65 antibodies. Confocal microscopy of
monolayers fixed and labeled 2 h after wounding revealed
that both proteins localize to the extending lamellipodia
(Fig. 7, a–c). Within the lamellipodia, FE65 and APP colo-
calized in a thin line near the lamellipodial edge. Interest-
ingly, not all of the lamellipodia induced by wounding
were labeled with APP or FE65 antibodies, suggesting that
these proteins are specifically found in lamellipodia in
a particular functional state. This is in agreement with
the published observations for Mena, which is found in
protruding, but not retracting, lamellipodia (Rottner et
al., 1999a). Importantly, immunofluorescent labeling of
wounded MDCK cell monolayers with both APP and
Mena antibodies suggested that induced lamellipodia that
contained APP tended to also contain Mena (Fig. 7, g–i).
This supports the idea that an FE65–APP complex local-
izes to mobile membranes and might function in regula-
tion of membrane motility.
To ensure that the protruding edges that contained APP
and FE65 were lamellipodia induced by wounding and not
just a general property common to all edges of MDCK cells,
we labeled clusters of MDCK cells with APP and FE65 an-
tibodies without induction of motility by wounding. Under
these conditions, MDCK cells are “resting” and do not typi-
cally extend lamellipodia (Fenteany et al., 2000). APP and
FE65 sometimes localized to cell–cell contact sites, but did
not localize to the edges of the stationary clusters where
there was no contact with other cells (Fig. 7, d–f).
 
Acceleration of Wound Healing by APP and FE65
 
Wound healing has been used previously as a measure of
the rate of cell migration or movement (Rosen and Mis-
feldt, 1980; Fenteany et al., 2000). In this context, the
Figure 5. APP and FE65
colocalize with  1-integrins
and actin in lamellipodia.
(a–e) H4 cells triple labeled
with APP polyclonal antibodies
(a),   1-integrin monoclonal
antibody (b), and Oregon
green–conjugated phalloidin
(c). Overlap of all three pro-
teins is indicated by white in
the overlay (d). (f–j) H4 cells
triple labeled with FE65
polyclonal antibody (f),  1-
integrin monoclonal antibody
(g), and Oregon green–conju-
gated phalloidin (h). Overlap
of all three proteins is indi-
cated by white in the overlay
(i). (e and j) Cross-correla-
tion analysis of APP and
FE65 colocalization with
 1-integrins and actin in fo-
cal complexes. Lines were
drawn perpendicular to the
lamellipodial edge (shown in
orange and labeled a –e  for
APP and f –k  for FE65).
The intensities were deter-
mined along each line and
the cross-covariograms cal-
culated as described in Mate-
rials and Methods. All of
the cross-covariograms have
peaks  0.5, indicating signif-
icant correlation. None have
a displacement greater than
the half-width at half-height,
indicating colocalization.
Bars, 10  m. 
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terms “cell migration” and “cell movement” are meant to
encompass any of the mechanisms involved in such pro-
cesses, including but not limited to actin dynamics, mem-
brane dynamics, and adhesion. As an assay for the possi-
ble role of the APP–FE65 complex in cell movement, we
measured the rate of closure of wounds formed as de-
scribed above. We compared wound closure 1 d after
wounding of confluent monolayers of wild-type MDCK
cells, MDCK cells stably transfected with APP or FE65,
and MDCK cells stably transfected with both APP and
FE65. As a measure of wound closure, we scored wounds
as fully closed, partially closed, or fully open (Table I).
None of the wild-type wounds had closed after 1 d of
wound healing (
 
n
 
 
 
 
 
 25). With APP overexpression, 17%
of the wounds were completely closed and 74% were par-
tially closed after 1 d (
 
n
 
 
 
 
 
 23). During the same period,
91% of the wounds were completely closed and 9% were
partially closed when cells expressed both APP and FE65
(
 
n
 
 
 
 
 
 57). Similar results were seen with additional stably
overexpressing clonal cell lines. The effects of FE65 and
APP together could not be accounted for by FE65 alone
since overexpression of FE65, but not APP, yielded com-
plete closure of only 20% of the wounds (
 
n
 
 
 
 
 
 20). Thus,
APP and FE65 accelerate wound closure, and the effects
of either protein are greatly enhanced by additional over-
expression of the other, consistent with a role for an APP–
FE65 complex in regulation of cell movement.
Figure 6. FE65 and APP remain associated with focal com-
plexes left behind after detachment of lamellipodia. (a and b) H4
cells were labeled with polyclonal FE65 antibodies and mono-
clonal   1-integrin antibody. Where a lamellipodium was de-
tached from the substrate, the integrin-dependent focal complex
was left behind and labeled with both FE65 antibodies (a) and in-
tegrin antibody (b). (c and d) H4 cells were labeled with APP
polyclonal antibody and X11/Mint monoclonal antibody. Where
lamellipodia were detached from the substrate, adhesion sites left
behind were labeled with APP antibody (c), but not with X11/
Mint antibody (d). (e–g) Similar adhesion sites that are double la-
beled with APP monoclonal antibodies (e) and Mena polyclonal
antibody (f). Overlap between APP and Mena in adhesion sites is
indicated by yellow in the overlay (g). Arrowheads point to areas
that contain high levels of both APP and Mena. Bars, 10  m.
Figure 7. FE65 and APP colocalize in protruding lamellipodia in-
duced by wounding. (a–c) Lamellipodial protrusion was induced
by wounding a confluent monolayer of MDCK cells stably trans-
fected with both APP and FE65. The monolayer was allowed to re-
cover for 2 h, enough time to allow lamellipodial extension into the
wound, then fixed and labeled with FE65 and APP antibodies. (a)
High magnification image of an extending lamellipodium labeled
with FE65 polyclonal antibodies. (b) The same lamellipodium la-
beled with APP monoclonal antibodies. (c) Overlay of the images
in a and b. Colocalization of FE65 and APP is indicated by yellow
in the overlay. APP and FE65 colocalize in a fine line at the edge
of the extending lamellipodium, consistent with localization in fo-
cal complexes. (d–f) Lower magnification image of clusters of
“resting” MDCK cells labeled with FE65 (d) and APP (e) antibod-
ies. (f) Overlay of the images in panels d and e. APP and FE65
colocalize at cell–cell contacts (arrows) but not at the edges of the
clusters (arrowheads). (g–i) High magnification image of an ex-
tending lamellipodium induced by wounding and labeled with
Mena polyclonal antibodies (g) and APP monoclonal antibodies
(h). Colocalization is indicated by yellow in the overlay (i). 
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We then determined the rate of migration of cells along
the wound edge. FE65 and APP overexpression increased
the rate at which the wound edge cells traveled when com-
pared with cells transfected with only APP (Fig. 8). By
15 h of recovery, the differences in the distance that the FE65
and APP overexpressing cells had traveled, compared with
the APP overexpressing cells, reached significance (
 
n
 
 
 
 
 
18, 
 
P
 
 
 
 
 
 0.05 by ANOVA and Fisher’s PLSD post hoc
test). The morphology of the confluent cells and the cells
at the wound edge was not noticeably changed upon trans-
fection with APP or FE65 (data not shown). These data
show that FE65 and APP increase the rate of migration of
cells at the wound edge. Although we cannot distinguish
between changes in the rate of movement due to altered
adhesion, altered actin dynamics, or both, these data
strongly support a role for an FE65–APP complex in regu-
lation of cell movement.
 
Discussion
 
Here we provide compelling evidence that APP is involved
in cell motility and that this function of APP is modulated
by FE65. The APP-dependent increase in the rate of
cell migration was enhanced upon FE65 overexpression.
Moreover, APP and FE65 colocalized in adhesion sites of
dynamic but not static membranes. Lending additional
support for a role for an APP–FE65 complex in regulation
of cell movement, we have recently found that APP and
FE65 colocalize in another type of mobile membrane, the
neuronal growth cone, in vivo (Sabo, S.L., A.F. Ikin, J.D.
Buxbaum, P. Greengard, unpublished observations).
Based on the data presented here and on previously
published results, we envision that APP and FE65 regulate
lamellipodial motility as part of a larger macromolecular
complex (Fig. 9). It has been shown previously that FE65
and Mena interact in cell lysates (Ermekova et al., 1998).
We have shown here that FE65 and APP colocalize with
Mena in lamellipodia and that both APP and Mena inter-
act with FE65 simultaneously. In turn, Mena is thought to
regulate the actin cytoskeleton through its interaction with
profilin (Gertler et al., 1996; Lanier et al., 1999; Lanier and
Gertler, 2000). Interestingly, the FE65 and profilin binding
sites in Mena overlap, suggesting that the APP–FE65 com-
plex could negatively regulate the association of Mena
with profilin. Integrins concentrate in lamellipodial adhe-
sion sites (Hotchin and Hall, 1995; Rottner et al., 1999b),
where, as demonstrated here, they colocalize with APP
and FE65. There are two NPXY motifs in the cytoplasmic
domain of 
 
 1-integrins (Howland et al., 1995). It is possi-
ble that the more NH2-terminal PID of FE65 interacts
with one of them. We do not yet know whether the various
proteins of this macromolecular complex might interact si-
multaneously or sequentially to regulate cell movement.
Table I. Wound Closure after 1 d
Fully closed Partially closed Fully open Totals
 APP/ FE65 0 0 25 25
 APP/ FE65 4 6 10 20
 APP/ FE65 4 17 2 23
 APP/ FE65 52 5 0 57
Totals 60 28 37 125
Confluent monolayers of wild-type MDCK cells ( APP/ FE65), MDCK cells stably
overexpressing APP ( APP/ FE65) or FE65 ( APP/ FE65), and MDCK cells
stably overexpressing both APP and FE65 ( APP/ FE65), grown on grids, were
wounded with a pipette tip. The wounds were allowed to heal for 1 d and then examined
at grid intersections and scored as fully closed, partially closed, or fully open.
Figure 8. FE65 enhances the ability of APP to increase the rate
of wound healing. Confluent monolayers of MDCK cells overex-
pressing APP ( APP/ FE65; a, c, e, and g) or both APP and
FE65 ( APP/ FE65, b, d, f, and h) were grown on grids then
wounded with a pipette tip. The wounds were photographed im-
mediately after wounding (a and b). The same points on the grids
were again photographed 9 (c and d), 12 (not shown), 15 (e and f),
18 (not shown), and 21 h (g and h) after wounding. (i) The distance
the wound edges had traveled was determined at the same three
points on each of six wounds. The data represent means   SE.
*P   0.05, **P   0.001, and **P   0.0001 by ANOVA. Similar re-
sults were seen with two additional FE65 overexpressing clones.The Journal of Cell Biology, Volume 153, 2001 1412
We propose that at least some of the effects of this APP-
and FE65-containing macromolecular complex on cell
movement are mediated by Mena. It has recently been
shown that lamellipodial Mena regulates cell motility in fi-
broblasts (Bear et al., 2000). In contrast to the increase in
cell movement caused by FE65 and APP, Mena decreases
cell motility. In addition, Ena, the Drosophila homologue
of Mena, negatively regulates growth cone migration
through an interaction with Robo, a transmembrane re-
ceptor that mediates repulsion of axons at the midline
(Bashaw et al., 2000). It is possible that Mena acts as a
switch, either binding to Robo or to the FE65–APP com-
plex: when Mena binds to Robo, motility is inhibited, but
when conditions are shifted so that Mena associates with
the FE65–APP complex rather than with Robo, the inhibi-
tion is released and motility increases. Because the nega-
tive regulation of motility by Mena was seen by Bear et al.
(2000) with both overexpression and underexpression in
lamellipodia, it is likely that in an “unstimulated” state
Mena associates with a Robo-like receptor to negatively
regulate motility, then, in response to some signal, Mena is
recruited to the FE65–APP complex and away from the
Robo-like receptor. Overexpression of FE65 and APP
might increase the local concentration of the FE65–APP
complex sufficiently to recruit some Mena from a Robo-
like receptor to FE65–APP. We do not yet know which
signals regulate the interaction between FE65 and Mena
or FE65 and APP. If Mena only binds to FE65 when FE65
is complexed with APP, either interaction could serve as a
source of regulation.
To move, cells need to anchor their motile membranes
to the surface or matrix over which they crawl, but these
anchors need to be more dynamic than the adhesion sites
found in stationary membranes. We show that FE65 and
APP colocalize with  1-integrins in relatively unstable fo-
cal complexes, but are not found in more stable focal ad-
hesions. This is especially interesting since focal complexes
can be precursors to focal adhesions (Rottner et al.,
1999b), and until now there was, to our knowledge, no
known difference in the biochemical composition of these
two kinds of adhesion sites. The APP–FE65 complex may
help destabilize adhesion sites. The effects of FE65 and
APP on cell migration in the wound-healing assay might
be due to changes in adhesion.
Since we have shown previously that FE65 increases the
trafficking of APP to the cell surface (Sabo et al., 1999),
we propose that FE65 regulates the role of APP in cell
movement by targeting APP to the cell surface. APP
might function there as a transmembrane molecule or as a
secreted fragment. Conditioned medium from cells over-
expressing APP did not significantly increase the rate of
migration of the wound edges in the wound-healing assay
(data not shown). Unfortunately, these experiments did
not allow us to distinguish between these two mechanisms,
since the local concentration of secreted APP fragments at
the lamellipodia might not be as high during bathing in
conditioned medium as it is when APP fragments are se-
creted directly from the wound edge cells.
There is some evidence to support the idea that the role
of APP and FE65 in regulation of cell movement may be
directly related to the proteolytic processing of APP. We
have shown previously that FE65 increases the proteolytic
processing of APP (Sabo et al., 1999). In addition, TACE,
an ADAM family protease, cleaves APP at the cell surface
in response to PKC activity (Buxbaum et al., 1998), which
is also known to stimulate cell motility. Integrin activity is
similarly regulated by proteolytic processing of its  -sub-
units (Delwel et al., 1996), probably by ADAM family
proteases (Chen et al., 1999). Secreted APP fragments
could compete with extracellular matrix ligands for bind-
ing to integrins, or to an APP ligand, decreasing the
strength of an adhesion site and promoting motility. It has
been shown that exogenous application of APP fragments
can increase neurite outgrowth (Koo et al., 1993; Jin et al.,
1994; Perez et al., 1997). Moreover, the most abundant se-
creted APP fragments contain a sequence, RHDS, that re-
sembles the integrin binding site on the  1-integrin extra-
cellular matrix ligand, fibronectin (Sabo et al., 1995), and,
therefore, can potentially interact with integrins through
this sequence. It is interesting to note that presenilins,
which also regulate the proteolytic processing of APP
(Haass and De Strooper, 1999), have recently been found
at the surface of lamellipodia (Schwarzman et al., 1999).
Recently, there has been great interest in proteins that
serve dual functions in regulation of actin-based mem-
brane motility and in transport of proteins to or from the
plasma membrane. For example, members of the Rho
family of small GTP-binding proteins regulate cell motility
and are involved in regulation of the endocytic pathway
(Lamaze et al., 1996; Kroschewski et al., 1999; Merrifield
Figure 9. APP and FE65 probably regulate membrane motility
as part of a larger macromolecular complex. The schematic de-
picts the possible components of the macromolecular complex
and their putative interactions. FE65 might interact with APP
through its COOH-terminal PID and with Mena through its WW
domain. Mena modulates actin polymerization, possibly through
its interaction with profilin, whereas integrins are indirectly
linked to actin through a variety of integrin- and actin-binding
proteins, such as  -actinin. Regulation of the various interactions
shown could connect environmental cues to actin dynamics at the
lamellipodial focal complex.Sabo et al. APP and FE65 Regulate Cell Movement 1413
et al., 1999). In addition, both myosin II, an actin-based
motor protein, and cdc42, activation of which induces for-
mation of filopodial actin spikes, have been shown to regu-
late secretory trafficking (Musch et al., 1997; Kroschewski
et al., 1999). In addition to its role in actin-based mem-
brane motility, FE65 regulates the transport of APP to the
plasma membrane (Sabo et al., 1999). This places FE65 in
the growing family of dual function proteins.
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